United States newsroom

NORTHBROOK, Ill., Dec. 9, 2015 /PRNewswire/ -- Astellas today announced that results from the pivotal Phase 3 SECURE trial evaluating CRESEMBA® (isavuconazonium sulfate) in adult patients with...

-- Updated results evaluating safety, tolerability and antileukemic activity of gilteritinib in AML, a rare, aggressive blood cancer, presented at American Society of Hematology annual meeting --...

Moburg to lead stakeholder engagement initiatives in the U.S. and in support of the Americas NORTHBROOK, IL, Dec. 3, 2015 — Astellas Pharma recently announced that Christeen Moburg has been...

November’s Bladder Health Month (#NovBHealth) Activities Aim to Raise Awareness and Reduce the Embarrassment of Bladder Issues Baltimore, MD, November 23, 2015—During Bladder Health Month, The...

NORTHBROOK, Ill., Nov. 17, 2015 /PRNewswire/ -- Astellas US, LLC, a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today announced several abstracts, including an oral presentation...

Employees surveyed say company culture and inclusion are top in the area NORTHBROOK, Ill., Nov. 13, 2015 — Astellas today was recognized as one of the top 20 large companies to work for in the...

NORTHBROOK, Ill., Nov. 12, 2015 /PRNewswire/ -- Astellas recently announced the appointment of Dr. Peter Sandor as vice president, head of oncology therapeutic area in Marketing Strategy. In this...

NORTHBROOK, Ill, Nov. 3, 2015 — Nearly 300 Astellas Pharma corporate services’ employees participated in a variety of activities on Oct. 28 to support the programming of Clearbrook, a...

NORTHBROOK, Ill., Oct. 27, 2015 /PRNewswire/ -- Astellas recently announced that Doug Geiger has been promoted to the position of vice president, head of New Therapeutic Areas in Marketing...

Astellas recognized for career opportunities, work/life benefits NORTHBROOK, IL, Sept. 22, 2015 —Astellas Pharma today was named one of Working Mother Magazine’s 100 Best Companies in the U.S....